• 1. Michael additions of 1,2-dihydro-3H-indol-3-ones and some reactions of Michael adducts with ammonium acetate
  Tomomi Kawasaki,Chen-Ying Tang,Hiroyuki Nakanishi,Shuiti Hirai,Tomohisa Ohshita,Mami Tanizawa,Motomu Himori,Hiroshi Satoh,Masanori Sakamoto,Keiko Miura,Fumio Nakano J. Chem. Soc. Perkin Trans. 1 1999 327
• 2. Synthesis of 2-allyl-2,3-dihydro-1H-indol-3-ones using in situ Claisen rearrangement of 2,3-dihydro-1H-indol-3-ones with allyl alcohols
  Tomomi Kawasaki,Kouhei Masuda,Yasutaka Baba,Romi Terashima,Kana Takada,Masanori Sakamoto J. Chem. Soc. Perkin Trans. 1 1996 729
• 3. BOINPYs: facile synthesis and photothermal properties triggered by photoinduced nonadiabatic decay
  Lizhi Gai,Ruijing Zhang,Xiuguang Shi,Zhigang Ni,Sisi Wang,Jun-Long Zhang,Hua Lu,Zijian Guo Chem. Sci. 2023 14 1434

Professional Introduction to 1-acetyl-2,3-dihydro-1H-indol-3-one (CAS No. 16800-68-3)

1-acetyl-2,3-dihydro-1H-indol-3-one, identified by its Chemical Abstracts Service (CAS) number 16800-68-3, is a heterocyclic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal biology. This compound belongs to the indole derivatives family, a class of molecules widely recognized for their diverse biological activities and potential therapeutic applications. The structural framework of 1-acetyl-2,3-dihydro-1H-indol-3-one incorporates an acetyl group at the 1-position and a hydroxyl group at the 3-position of a saturated indole ring, which contributes to its unique chemical properties and reactivity. These structural features make it a valuable scaffold for further chemical modifications and derivatization, enabling the development of novel bioactive molecules.

The indole core of 1-acetyl-2,3-dihydro-1H-indol-3-one is a privileged structure in drug discovery, owing to its presence in numerous natural products and biologically active compounds. Over the years, researchers have explored various derivatives of indole to identify molecules with pharmacological relevance. The acetyl group in this compound not only influences its solubility and metabolic stability but also serves as a site for further functionalization, allowing chemists to tailor its biological profile for specific applications. For instance, the acetyl moiety can be hydrolyzed or converted into other functional groups, such as amides or esters, to enhance binding affinity or metabolic clearance.

Recent advancements in computational chemistry and high-throughput screening have facilitated the rapid identification of promising candidates like 1-acetyl-2,3-dihydro-1H-indol-3-one for drug development. These techniques enable researchers to predict the biological activity of molecules based on their structural features, thereby accelerating the discovery process. In particular, virtual screening methods have been employed to dock this compound against various biological targets, including enzymes and receptors involved in critical disease pathways. Preliminary computational studies suggest that 1-acetyl-2,3-dihydro-1H-indol-3-one may exhibit inhibitory activity against certain kinases and transcription factors, making it a potential lead compound for therapeutic intervention.

In vitro studies have begun to unravel the mechanistic aspects of 1-acetyl-2,3-dihydro-1H-indol-3-one, providing insights into its interactions with biological macromolecules. For example, research indicates that this compound can modulate the activity of cytochrome P450 enzymes, which are crucial for drug metabolism. By understanding how 1-acetyl-2,3-dihydro-1H-indol-3-one interacts with these enzymes, scientists can optimize its pharmacokinetic properties to improve bioavailability and reduce off-target effects. Additionally, the compound’s ability to cross cell membranes suggests potential applications in drug delivery systems designed for targeted therapy.

The synthesis of 1-acetyl-2,3-dihydro-1H-indol-3-one has been optimized through various synthetic routes to ensure high yield and purity. Traditional methods involve cyclization reactions followed by acetylation steps, while modern approaches leverage transition metal-catalyzed reactions for more efficient synthesis. Advances in green chemistry have also prompted researchers to explore solvent-free and catalytic methods that minimize waste and energy consumption. These innovations not only improve the sustainability of producing 1-acetyl-2,3-dihydro-1H-indol-3-one but also enhance scalability for industrial applications.

The pharmaceutical industry has shown interest in indole derivatives like 1-acetyl-2,3-dihydro-1H-indol-3-one due to their broad spectrum of biological activities. Preclinical studies have demonstrated that derivatives of this compound exhibit anti-inflammatory, anticancer, and antimicrobial properties. For instance, modifications at the 5-position of the indole ring have led to compounds with enhanced efficacy against certain cancer cell lines. These findings underscore the importance of 1-acetyl-2,3-dihydro-1H-indol-3-one as a starting point for developing novel therapeutics.

Future research directions may focus on exploring the structure–activity relationships (SAR) of 1-acetyl-2,3-dihydro-1H-indol-3-one to identify key structural determinants responsible for its biological effects. By systematically modifying different parts of the molecule, researchers can generate libraries of analogs with tailored properties. High-resolution techniques such as X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy will be instrumental in elucidating the binding modes of these compounds with target proteins.

The role of 1-acetyl-2,3-dihydro-1H-indol-3-one in medicinal chemistry is further highlighted by its potential as a chiral building block. The presence of stereogenic centers allows for the synthesis of enantiomerically pure derivatives, which can exhibit distinct pharmacological profiles compared to racemic mixtures. Such enantiomerically enriched compounds are increasingly sought after in drug development due to their improved selectivity and reduced side effects.

In conclusion, 1-acetyl - 2 , 3 - dihydro - 1 H - indol - 3 - one ( CAS No . 16800 - 68 - 3 ) represents a fascinating compound with significant promise in pharmaceutical research . Its unique structural features , coupled with emerging evidence from computational and experimental studies , position it as a valuable scaffold for developing novel bioactive molecules . As research continues to uncover new therapeutic applications , this indole derivative is poised to play an important role in addressing unmet medical needs .

• 41042-12-0(1-propyl-2,3-dihydro-1H-indole-2,3-dione)
• 16078-35-6(1,1'-(Indoline-1,5-diyl)diethanone)
• 4290-94-2(1-ethyl-2,3-dihydro-1H-indole-2,3-dione)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)